Table 4.
Susceptibility* to extended-spectrum beta-lactams and cephalosporins by selected AmpC-hyperproducing E. coli isolates obtained from this study
|
Isolate |
ST |
Ampicillin |
Amoxicillin and clavulanic acid |
Cefoxitin |
Cefpodoxime |
Ceftazidime |
Cefotaxime |
Cefepime |
|---|---|---|---|---|---|---|---|---|
|
ED0006b |
ST351 |
S |
S |
R |
S |
S |
S |
S |
|
ED0020c |
ST8977 |
R |
R |
R |
R |
S |
I |
S |
|
ED0023c |
ST56 |
R |
R |
S |
R |
S |
S |
S |
|
ED0040c |
ST5729 |
R |
R |
S |
R |
I |
I |
S |
|
ED0050c |
ST1730 |
R |
R |
I |
R |
S |
S |
S |
|
ED0058c |
ST8977 |
R |
R |
R |
R |
S |
I |
S |
|
ED0058g |
ST1079 |
R |
R |
S |
R |
S |
S |
S |
*Isolates were determined to be S, I or R as per CLSI guidelines, Table S1.
I, intermediate; R, resistant; S, sensitive; ST, sequence type.